Induction of hepatic glutathione S-transferase and UDP-glucuronosyltransferase activities by ketamine in rats

Acta Anaesthesiologica Taiwanica

Volumn 46, Issue 1, 2008, Pages 2-7

  Chan, Wei Hung ^a   Su, Hung Chang ^a   Hung, Ming Hui ^a   Sun, Wei Zen ^a   Fan, Shou Zen ^a   Hsiao, Po Ni ^a   Ueng, Tzuu Huei ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Glucuronosyltransferase; Glutathione transferase; Ketamine

Indexed keywords

GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; KETAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; ENZYME ACTIVITY; ENZYME INDUCTION; LIVER CYTOSOL; LIVER MICROSOME; MALE; NONHUMAN; RAT;

EID: 42549138425     PISSN: 02541319     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1875-4597(08)60013-2     Document Type: Article

References (29)

1. Reich DL, Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth 1989;36:186-97.
2. Ersek RA. Dissociative anesthesia for safety's sake: ketamine and diazepam-a 35-year personal experience. Plast Reconstr Surg 2004;113:1955-9.
3. Kogan A, Efrat R, Katz J, Vidne BA. Propofol-ketamine mixture for anesthesia in pediatric patients undergoing cardiac catheterization. J Cardiothorac Vasc Anesth 2003; 17:691-3.
4. Carr DB, Goudas LC, Denman WT, Brookoff D, Staats PS, Brennen L, Green G, et al. Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study. Pain 2004;108:17-27.
5. Lauretti GR, Lima IC, Reis MP, Prado WA, Pereira NL. Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management. Anesthesiology 1999; 90:1528-33.
6. Jansen KL. A review of the non-medical use of ketamine: use, users and consequences. J Psychoactive Drug 2000;32: 419-33.
7. Chan WH, Sun WZ, Ueng TH. Induction of rat hepatic cytochrome P-450 by ketamine and its toxicological implications. J Toxicol Environ Health A 2005;68:1581-97.
8. Byer DE, Gould AB Jr. Development of tolerance to ketamine in an infant undergoing repeated anesthesia. Anesthesiology 1981;54:255-6.
9. Marietta MP, White PF, Pudwill CR, Way WL, Trevor AJ. Biodisposition of ketamine in the rat: self-induction of metabolism. J Pharmacol Exp Ther 1976;196:536-44.
10. Chan WH, Chen TL, Chen RM, Sun WZ, Ueng TH. Propofol metabolism is enhanced after repetitive ketamine administration in rats: the rote of cytochrome P-450 2B induction. Br J Anaesth 2006;97:351-8.
11. Marietta MP, Vore ME, Way WL, Trevor AJ. Characterization of ketamine induction of hepatic microsomal drug metabolism. Biochem Pharmacol 1977;26:2451-3.
12. Meyer UA, Hoffmann K. Phenobarbital-mediated changes in gene expression in the liver. Drug Metab Rev 1999;31: 365-73.
13. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51-88.
14. Kiang TK, Ensom MH, Chang TK. UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther 2005;106:97-132.
15. Wells PG, Mackenzie PI, Chowdhury JR, Guillemette C, Gregory PA, Ishii Y, Hansen AJ, et al. Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos 2004;32:281-90.
16. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
17. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130-9.
18. Ueng TH, Hwang WP, Chen RM, Wang HW, Kuo ML, Park SS, Guengerich FP. Effects of motorcycle exhaust on cytochrome P-450-dependent monooxygenases and glutathione S-transferase in rat tissues. J Toxicol Environ Health A 1998;54:509-27.
19. Mackenzie PI, Hänninen O. A sensitive kinetic assay for UDP-glucuronosyltransferase using 1-naphthol as substrate. Anal Biochem 1980;109:362-8.
20. Ueng TH, Wang HW, Hung CC, Chang HL. Effects of motorcycle exhaust inhalation exposure on cytochrome P-450 2B1, antioxidant enzymes, and lipid peroxidation in rat liver and lung. J Toxicol Environ Health A 2004;67:875-88.
21. Kuzner J, Sprogar S, Volk J, Drevensek J. Fatal reaction after repeated administration of ketamine-medetomidine mixture to male Wistar rats. J Vet Pharmacol Ther 2006; 29S1:340-1.
22. Kawamoto T, Sueyoshi T, Zelko I, Moore R, Washburn K, Negishi M. Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol Cell Biol 1999;19:6318-22.
23. Sugatani J, Kojima H, Ueda A, Kakizaki S, Yoshinari K, Gong QH, Owens IS, et al. The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 2001;33:1232-8.
24. Soars MG, Petullo DM, Eckstein JA, Kasper SC, Wrighton SA. An assessment of UDP-glucuronosyltransferase induction using primary human hepatocytes. Drug Metab Dispos 2004;32:140-8.
25. Ainbinder E, Bergelson S, Pinkus R, Daniel V. Regulatory mechanisms involved in activator-protein-1 (AP-1)-mediated activation of glutathione-S-transferase gene expression by chemical agents. Eur J Biochem 1997;243:49-57.
26. Sugiyama T, Kubota Y, Shinozuka K, Yamada S, Yamada K, Umegaki K. Induction and recovery of hepatic drug metabolizing enzymes in rats treated with Ginkgo biloba extract. Food Chem Toxicol 2004;42:953-7.
27. Greenblatt DJ. Clinical pharmacokinetics of oxazepam and lorazepam. Clin Pharmacokinet 1981;6:89-105.
28. Ishii Y, Takami A, Tsuruda K, Kurogi A, Yamada H, Oguri K. Induction of two UDP-glucuronosyltransferase isoforms sensitive to phenobarbital that are involved in morphine glucuronidation: production of isoform-selective antipeptide antibodies toward UGT1.1r and UGT2B1. Drug Metab Dispos 1997;25:163-7.
29. Lotsch J. Morphine metabolites as novel analgesic drugs? Curr Opin Anaesthesiol 2004;17:449-53.